# Estuary Biotherapeutics funding rounds and investors

As of 17 Oct 2026, Estuary Biotherapeutics has raised $93M across 1 verified round on record; latest: $93 million Series A led by RA Capital Management, announced 15 Oct 2026.

A biotechnology company developing genetic medicines for patients with serious kidney diseases

Website: https://estuarybio.com/  
Headquarters: Menlo Park, Calif. & Newton, Mass.  
Page: https://fireround.dev/companies/estuary-biotherapeutics-2

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-15 | Series A | $93 million | RA Capital Management | 4BIO Capital, Biogen New Ventures, Deep Track Capital, GV (Google Ventures), National Kidney Foundation Innovation Fund, Pivotal bioVenture Partners, UPMC Enterprises | [estuarybio.com](https://estuarybio.com/news/estuary-series-a), [businesswire.com](https://www.businesswire.com/news/home/20261015160770/en/Estuary-Biotherapeutics-Launches-with-%24103-Million-to-Develop-Targeted-Gene-Therapies-for-Kidney-Disease), [app.fundz.net](https://app.fundz.net/fundings/estuary-biotherapeutics-funding-round-series-a-11c497) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.